Dermal delivery of HSP47 siRNA with NOX4-modulating mesoporous silica-based nanoparticles for treating fibrosis

Abstract

Fibrotic diseases such as scleroderma have been linked to increased oxidative stress and upregulation of pro-fibrotic genes. Recent work suggests a role of NADPH oxidase 4 (NOX4) and heat shock protein 47 (HSP47) in inducing excessive collagen synthesis, leading to fibrotic diseases. Herein, we elucidate the relationship between NOX4 and HSP47 in fibrogenesis and propose to modulate them altogether as a new strategy to treat fibrosis. We developed a nanoparticle platform consisting of polyethylenimine (PEI) and polyethylene glycol (PEG) coating on a 50-nm mesoporous silica nanoparticle (MSNP) core. The nanoparticles effectively delivered small interfering RNA (siRNA) targeting HSP47 (siHSP47) in an in vitro model of fibrosis based on TGF-β stimulated fibroblasts. The MSNP core also imparted an antioxidant property by scavenging reactive oxygen species (ROS) and subsequently reducing NOX4 levels in the in vitro fibrogenesis model. The nanoparticle was far superior to n-acetyl cysteine (NAC) at modulating pro-fibrotic markers. In vivo evaluation was performed in a bleomycin-induced scleroderma mouse model, which shares many similarities to human scleroderma disease. Intradermal administration of siHSP47-nanoparticles effectively reduced HSP47 protein expression in skin to normal level. In addition, the antioxidant MSNP also played a prominent role in reducing the pro-fibrotic markers, NOX4, alpha smooth muscle actin (α-SMA), and collagen type I (COL I), as well as skin thickness of the mice.

Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles

“…MSNPs have been reported to have reactive oxygen species (ROS), hydroxyl radical, and free radical scavenging capability [167], [168], [169]. ROS scavenging by MSNP also attenuates NOX4 mRNA expression in melanoma cells in vitro [168].…”

Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?

“…Numerous miRNA-based therapeutics are already in development for various diseases such as HCV infection, various cancers, heart failure, and fibrosis [125]. Novel technologies for optimal delivery of siRNAs, miRNA mimics, and antimiR oligonucleotides are being explored [126]. …”

Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment

“…Inorganic nanoparticles exhibit unique tunable properties including the rigid surface amenable to chemical modification and their unique intrinsic properties (e.g., superparamagnetic property of iron oxide NPs, 55 size-dependent optical features of quantum dots, 56 photothermal property of gold and silver NPs, 57 antioxidant property of mesoporous silica nanoparticle (MSNP), 58 drug-loading capacity in MSNP pores). They are also typically easier to synthesize with high reproducibility and scalability.…”